Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 2/20 | 0.48 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.47 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.47 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL209320 | 0.97 | ALDH1A1 (0.52) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Phosphoric Acid SCHEMBL15110084 | 0.88 | HPGD (0.48) | ALDH1A1TSHRNPC1RAB9ACA12 | |
| Hydrochloric Acid SCHEMBL1876474 | 0.86 | CYP1A2 (0.53) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Hydrochloric Acid SCHEMBL28417225 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| SCHEMBL39645 | 0.82 | CYP1A2 (0.55) | ALDH1A1TSHRAOC3MGLLNPC1 | |
| Hydrochloric Acid SCHEMBL3895103 | 0.81 | AOC3 (0.56) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Hydrochloric Acid SCHEMBL2115265 | 0.81 | AOC3 (0.56) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Hydrochloric Acid SCHEMBL10565954 | 0.81 | ALDH1A1 (0.61) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Hydrochloric Acid SCHEMBL27833055 | 0.81 | ALDH1A1 (0.48) | ALDH1A1TSHRAOC3MGLLGRIN2D | |
| Pyrophosphoric Acid SCHEMBL15110085 | 0.81 | TSHR (0.46) | ALDH1A1TSHRNPC1RAB9ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 247 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017210262-A1 | PREVENTION AND TREATMENT OF VIRAL INFECTIONS | BARANOWITZ STEVEN (US) | 2017-12-07 | — | — | WO | claimed |
| US-20120149849-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | KNC NER ACQUISITION SUB, INC. (US) | 2012-06-14 | — | — | US | claimed |
| EP-2348835-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | KNC NER Acquisition Sub, Inc. (US) | 2011-08-03 | — | — | EP | claimed |
| US-7981261-B2 | Integrated device and substrate for separating charged carriers and reducing photocorrosion and method for the photoelectrochemical production of electricity and photocatalytic production of hydrogen | UCHICAGO ARGONNE, LLC (US) | 2011-07-19 | — | — | US | claimed |
| EP-1475094-B1 | Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use | USTAV EX BOTAN AKADEMIE VED CE (CZ) | 2010-07-28 | — | — | EP | claimed |
| US-20100113828-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | NERITES CORPORATION (US) | 2010-05-06 | — | — | US | claimed |
| WO-2010037045-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | NERITES CORPORATION (US) | 2010-04-01 | — | — | WO | claimed |
| US-20070167466-A1 | \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2007-07-19 | — | — | US | claimed |
| US-20070105013-A1 | Integrated device and substrate for separating charged carriers and reducing photocorrosion and method for the photoelectrochemical production of electricity and photocatalytic production of hydrogen | UNITED STATES DEPARTMENT OF ENERGY | 2007-05-10 | — | — | US | claimed |
| US-20040265907-A1 | Juxtaposing affinity moieties to a semiconductor to effect changes in the charge pair separation characteristics when the affinity molecules are bound to the target; detecting target moieties in situ using nanocrystalline semiconductors; genome sequencing, forensics, assays, and drug screening | RAJH TIJANA (US) | 2004-12-30 | — | — | US | claimed |
| WO-2004098608-A1 | PYRAZOLO [4, 3-D]PYRIMIDINES, PROCESSES FOR THEIR PREPARATION AND METHODS OF USE | ÚSTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) | 2004-11-18 | — | — | WO | claimed |
| EP-1475094-A1 | Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use | Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) | 2004-11-10 | — | — | EP | claimed |
| EP-0311385-B1 | OPTICALLY ACTIVE HYDROXYBENZYLAMINE DERIVATIVE, OPTICALLY ACTIVE AMINE-BORON COMPOUND CONTAINING SAID DERIVATIVE, AND PROCESS FOR PRODUCING OPTICALLY ACTIVE COMPOUND BY USING SAID COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-02-03 | — | — | EP | claimed |
| EP-0091385-A1 | Process for the preparation of p-hydroxybenzyl nitriles or p-hydroxybenzyl amines | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-10-12 | — | — | EP | claimed |
| US-20240238297-A1 | USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS | CHIMERIX, INC. | 2024-07-18 | — | — | US | disclosed |
| CN-117903072-A | Dopa compound and preparation method and application thereof | 深圳市松柏科工股份有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-112980595-B | Recyclable multifunctional nano surfactant and preparation method thereof | 中国科学院生态环境研究中心 | 2022-03-18 | — | — | CN | disclosed |
| EP-0117528-A2 | Method and device for electrochemical detection | Rall, Gerhard, Dipl.-Ing., Arzt (DE) | 1984-09-05 | — | — | EP | disclosed |
| EP-0091385-A1 | Process for the preparation of p-hydroxybenzyl nitriles or p-hydroxybenzyl amines | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-10-12 | — | — | EP | disclosed |
| US-3968104-A | SOLVENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113828-A1 | MULTI-ARMED CATECHOL COMPOUND BLENDS | COMT, HAAO, PNMT | ALDH1A1 349/4885TSHR 4861/4885AOC3 127/4885 |
| US-20070167466-A1 | \"Pyrazolo [4,3-d]pyrimidines, processes for their preparation and methods of use\ | CBR3, PYM1, PNPO | ALDH1A1 1636/4885TSHR 893/4885AOC3 99/4885 |
| US-20240238297-A1 | USES AND METHODS FOR RECURRENT PRIMARY CNS NEOPLASMS | MKI67, BCL6, CBX6 | ALDH1A1 704/4885TSHR 2417/4885AOC3 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.